In an evolving regulatory environment, identifying compliance gaps early and closing them effectively is critical to inspection success. Our Gap Assessment & Remediation services help pharmaceutical and life sciences organizations evaluate their current compliance status, identify regulatory gaps, and implement practical, risk-based remediation solutions aligned with global and local regulatory expectations.
We go beyond gap identification—our focus is on closing gaps, strengthening systems, and achieving sustainable GMP/GxP compliance.
Comprehensive Regulatory Gap Assessment
Our structured GMP/GxP gap assessments are designed to benchmark your facility, processes, and quality systems against applicable regulatory requirements and inspection trends.
Scope of Gap Assessment
- GMP & GxP Compliance Assessment
- Quality Management System (QMS) review
- SOP structure, adequacy, and implementation check
- Batch Manufacturing & Control Records (BMR/BPR) review
- Deviation, CAPA, change control, and risk management evaluation
- Regulatory & Inspection Readiness Assessment
- CDSCO and Schedule M gap analysis
- US FDA cGMP readiness assessment
- WHO-GMP and EU GMP compliance review
- Pre-inspection and mock inspection gap identification
- System & Process-Specific Gap Analysis
- Data Integrity (ALCOA+) assessment
- Computer System Validation (CSV) & ERES gap analysis
- Cleaning validation and process validation review
- Warehouse, cold chain, and distribution practices assessment
Risk-Based Remediation & Compliance Enhancement
Gap identification without effective remediation adds little value. Our remediation services are designed to convert audit findings into clear, achievable, and regulator-accepted corrective actions.
Remediation Support Includes
- Development of risk-based remediation plans
- Root Cause Analysis (RCA) using proven methodologies
- CAPA definition, implementation, and tracking
- SOP creation, revision, and rollout support
- Hands-on implementation support at the shop-floor level
- Training and awareness programs for sustained compliance
Regulatory Standards Covered
Our gap assessment and remediation services are aligned with:
- Schedule M & CDSCO Guidelines
- US FDA cGMP
- WHO-GMP
- EU GMP
- ICH Q7, Q9, Q10
- GxP & Data Integrity requirements
This ensures your organization is prepared for both Indian regulatory inspections and global audits.
Deliverables You Can Act On
- Comprehensive gap assessment report with objective evidence
- Risk-ranking of gaps (critical, major, minor)
- Practical remediation roadmap with timelines
- CAPA documentation and closure support
- Management review summary for leadership decisions
Why Choose Our Gap Assessment & Remediation Services?
- Inspection-Driven Expertise
Built around real CDSCO, FDA, and WHO-GMP inspection expectations. - Practical & Implementable Solutions
Focused on what can be realistically executed and sustained. - Risk-Based Compliance Approach
Prioritizes high-impact gaps that regulators focus on. - End-to-End Support
From gap identification to full remediation and re-assessment. - Faster Compliance & Fewer Observations
Strengthens systems before inspections occur.
Industries We Support
- Pharmaceutical Formulation Manufacturing
- API & Intermediate Manufacturing
- Medical Device Manufacturers
- Contract Manufacturing Organizations (CMOs)
- Laboratories and Life Sciences Companies
- Start-ups and New Manufacturing Facilities
Close Compliance Gaps. Build Inspection Readiness.
With increasing regulatory scrutiny and risk-based inspections, organizations cannot afford reactive compliance. Our Gap Assessment & Remediation services help you proactively identify weaknesses, implement effective corrective actions, and build a robust compliance culture.
